Grey matter changes associated with medication-overuse headache: correlations with disease related disability and

Franz Riederer1, Marvin Marti, Roger Luechinger

  • 1Department of Neurology, Headache Unit, University Hospital Zurich, Zurich, Switzerland.

Abstract

Insights

Medication-overuse headache (MOH) is linked to psychiatric issues. Brain imaging reveals altered grey matter in pain and reward circuits, potentially explaining dependence in some patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Psychiatry

Background:

  • Medication-overuse headache (MOH) frequently co-occurs with psychiatric conditions.
  • Similarities between MOH and substance dependence suggest shared neurobiological underpinnings.
  • Investigating structural brain changes in MOH is crucial for understanding its pathophysiology.

Purpose of the Study:

  • To examine grey matter volume differences in patients with MOH and migraine.
  • To explore the relationship between grey matter changes and psychiatric comorbidities.
  • To investigate the role of pain and reward systems in MOH.

Main Methods:

  • Voxel-based morphometry was used to analyze structural MRI scans.
  • 29 patients with MOH and migraine were compared to healthy controls.
  • Psychiatric status was assessed using standardized questionnaires and clinical interviews.

Main Results:

  • Increased grey matter volume (GMV) was observed in the midbrain periaqueductal grey, thalamus, and ventral striatum.
  • GMV increases correlated with headache disability and anxiety levels.
  • Decreased GMV was found in frontal regions, including the orbitofrontal cortex and insula.

Conclusions:

  • Findings suggest impaired antinociceptive system function in MOH, modulated by anxiety.
  • Altered reward system function may underlie dependence in a subset of MOH patients.
  • Structural brain changes offer insights into the neurobiology of MOH and its psychiatric links.

Related Concept Videos

Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...